COHERUS
LIVE

Serial Number

90858291

Owner

COHERUS BIOSCIENCES, INC.

Attorney

Perry J. Viscounty

First Use Date

Jan 13, 2019

Filing Date

Jul 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

COHERUS Trademark

Serial Number: 90858291 • Registration: 6921362

COHERUS is a trademark filed by COHERUS BIOSCIENCES, INC. on July 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

COHERUS BIOSCIENCES, INC. (50 trademarks)

REDWOOD CITY, CA 94065

Entity Type: 03

COHERUS ONCOLOGY, INC. (11 trademarks)

333 Twin Dolphin Drive, Suite 600
Redwood City, CA 94065

Entity Type: 03

Trademark Details

Filing Date

July 30, 2021

Registration Date

December 13, 2022

First Use Anywhere

January 13, 2019

First Use in Commerce

January 13, 2019

Published for Opposition

September 27, 2022

Goods & Services

pharmaceuticals for human immune diseases and conditions; pharmaceuticals for use in stimulating white blood cell production; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammation; Pharmaceuticals for the treatment of cancer, autoimmune diseases, metabolic diseases, or ophthalmic diseases and conditions; Pharmaceutical preparations for the prevention and treatment of auto-immune, inflammatory, hematological, hepatological, cardiovascular, pulmonary, central nervous system, neurological system, pain, inflammation, dermatologic, gastro-intestinal, hormonal, psychiatric, infectious-related, viral, metabolic, oncologic, ophthalmic, respiratory, digital ulcers, musculo-skeletal, genitourinary, sexual dysfunction, and cerebrovascular diseases and disorders; vaccines; anxiolytics; anti-allergics; anti-infectives; pharmaceutical preparations for treatment of ocular diseases and disorders; pharmaceuticals for the treatment of oncology, immunology, ophthalmology diseases and disorders

providing information in the fields of health and medicine; consulting services in the field of pharmaceuticals and medical care

research, development and consulting services in the pharmaceutical research and biotechnology fields; consulting, research and development in the medical field

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 21, 2025 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 16, 2024 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 24, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 22, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2021 NWOS
NEW APPLICATION ENTERED
Aug 3, 2021 NWAP